【摘要】 目的探讨经尿道前列腺等离子电切术联合剜除术治疗前列腺增生症的临床效果。方法选取2018年1～12月我院收治的60例前列腺增生患者作为研究对象,根据随机数字表法分为对照组与研究组,每组各30例。研究组采用经尿道前列腺等离子电切术联合剜除术进行治疗,对照组采用经尿道前列腺等离子电切术治疗。比较两组患者的术后并发症发生情况、术后随访3个月各指标和手术期安全性。结果研究组患者的手术、膀胱冲洗、导管拔除、术后住院时间均短于对照组,术中出血量少于对照组,切除组织重量高于对照组,差异有统计学意义(P<0.05);两组患者术后的国际前列腺症状评分(IPSS)、最大尿流量(Qmax)、残余尿量(RU)比较,差异无统计学意义(P>0.05);研究组患者的并发症总发生率低于对照组,差异有统计学意义(P<0.05)。结论对前列腺增生症患者采用经尿道前列腺等离子电切术联合经尿道前列腺剜除术进行治疗,能够有效提高患者手术的安全性,明显降低术后并发症发生率,降低术后复发率,及增加尿控能力。更多还原

【Abstract】 Objective To explore the clinical effect of transurethral plasma resection of prostate combined with enucleation in the treatment of benign prostatic hyperplasia. Methods A total of 60 patients with benign prostatic hyperplasia treated in our hospital from January to December 2018 were divided into control group(n=30) and study group(n=30)by random number table method. The study group was treated with transurethral plasma resection of prostate combined with enucleation, while the control group was treated with transurethral plasma resection of prostate. The postoperative complications, indexes follow-up for 3 months and safety during operation were compared between the two groups. Results The operation time, bladder washing time, catheter extraction time and postoperative hospitalization time of the patients in the study group were shorter than those in the control group, the amount of bleeding during operation was less than that in the control group, and the weight of resected tissue was higher than that in the control group, the differences were statistically significant(P<0.05), but there were no significant differences in international prostate symptom score(IPSS), maximum urine flow(Qmax) and residual urine volume(RU) between the two groups(P>0.05). The total incidence of complications in the study group was lower than that in the control group, the difference was statistically significant(P<0.05). Conclusion Transurethral plasma resection of prostate combined with transurethral enucleation of prostate can effectively improve the safety of operation, significantly reduce the incidence of complications, reduce the recurrence rate and increase the ability of urinary control in patients with benign prostatic hyperplasia.更多还原